COLOMBINO, MARIA
 Distribuzione geografica
Continente #
AS - Asia 2.424
NA - Nord America 1.223
EU - Europa 731
SA - Sud America 399
Continente sconosciuto - Info sul continente non disponibili 122
AF - Africa 39
OC - Oceania 2
Totale 4.940
Nazione #
US - Stati Uniti d'America 1.143
SG - Singapore 984
CN - Cina 483
BR - Brasile 323
IT - Italia 297
HK - Hong Kong 248
VN - Vietnam 237
BD - Bangladesh 142
FR - Francia 125
NL - Olanda 111
JP - Giappone 108
KR - Corea 70
DE - Germania 46
CA - Canada 38
IN - India 37
GB - Regno Unito 36
AR - Argentina 24
FI - Finlandia 20
AT - Austria 19
ID - Indonesia 16
MX - Messico 16
IE - Irlanda 14
ZA - Sudafrica 13
CO - Colombia 12
EC - Ecuador 12
IL - Israele 12
PH - Filippine 11
VE - Venezuela 11
SA - Arabia Saudita 10
PL - Polonia 9
IQ - Iraq 8
RU - Federazione Russa 8
TH - Thailandia 7
UA - Ucraina 7
UY - Uruguay 7
UZ - Uzbekistan 7
AE - Emirati Arabi Uniti 6
JM - Giamaica 6
PK - Pakistan 6
HN - Honduras 5
KE - Kenya 5
TR - Turchia 5
CL - Cile 4
CZ - Repubblica Ceca 4
ES - Italia 4
HU - Ungheria 4
JO - Giordania 4
MA - Marocco 4
NP - Nepal 4
TN - Tunisia 4
AL - Albania 3
BG - Bulgaria 3
CR - Costa Rica 3
EG - Egitto 3
LT - Lituania 3
MY - Malesia 3
PT - Portogallo 3
SE - Svezia 3
BO - Bolivia 2
CH - Svizzera 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
KZ - Kazakistan 2
LV - Lettonia 2
OM - Oman 2
PY - Paraguay 2
SC - Seychelles 2
SI - Slovenia 2
TT - Trinidad e Tobago 2
AM - Armenia 1
AU - Australia 1
AZ - Azerbaigian 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CI - Costa d'Avorio 1
CU - Cuba 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GD - Grenada 1
GF - Guiana Francese 1
GR - Grecia 1
HR - Croazia 1
LB - Libano 1
LK - Sri Lanka 1
LS - Lesotho 1
LU - Lussemburgo 1
MM - Myanmar 1
MU - Mauritius 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
PE - Perù 1
PR - Porto Rico 1
QA - Qatar 1
Totale 4.814
Città #
Singapore 560
Santa Clara 279
Hong Kong 246
Hefei 159
San Jose 140
Beijing 105
Lauterbourg 97
Tokyo 95
Ashburn 94
Ho Chi Minh City 91
Seoul 69
Los Angeles 64
Hanoi 53
Dallas 51
São Paulo 35
Cavallino 30
Genoa 30
New York 29
San Gregorio di Catania 23
Buffalo 18
Council Bluffs 17
Rome 17
Amsterdam 16
Milan 15
Cagliari 14
Orem 14
Vienna 14
Dublin 13
Phoenix 13
Helsinki 12
Montreal 12
Da Nang 11
Frankfurt am Main 11
Mumbai 11
Boardman 10
Johannesburg 10
Minamishinagawa 10
Naples 10
Rio de Janeiro 10
Belo Horizonte 9
Guangzhou 9
Haiphong 9
Munich 9
Chennai 8
Düsseldorf 8
Hải Dương 8
Nuremberg 8
Brooklyn 7
Chicago 7
Tashkent 7
Dhaka 6
Manchester 6
Montevideo 6
Porto Alegre 6
Toronto 6
Turku 6
Washington 6
Bari 5
Curitiba 5
Maceió 5
Paris 5
Pisa 5
Riyadh 5
Salvador 5
Seattle 5
Sumaré 5
Warsaw 5
Araxá 4
Biên Hòa 4
Denver 4
Florence 4
Franca 4
Houston 4
Jacksonville 4
Jeddah 4
London 4
Marseille 4
Mexico City 4
Philadelphia 4
Poplar 4
Quảng Ngãi 4
Quận Một 4
Recife 4
Sala Baganza 4
San Francisco 4
Sassari 4
Shanghai 4
Terralba 4
Turin 4
Antioch 3
Atlanta 3
Bandung 3
Bogotá 3
Boston 3
Brescia 3
Buenos Aires 3
Bắc Ninh 3
Caracas 3
Changsha 3
Duque de Caxias 3
Totale 2.810
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 122
Four years of activity of the Melanoma Unit of Sassari across North Sardinia 119
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 88
Il CSCC: aspetti distintivi della patologia 82
Heterogeneous prevalence of mutations in KRAS, BRAF, and PIK3CA genes among Sardinian patients with colorectal carcinoma 76
Multiple primary melanomas from same patients present discrepant somatic alterations in main candidate genes 74
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 72
Liquid biopsy in clinical oncology 70
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 70
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 68
Genetic alterations in main candidate genes during melanoma progression. 67
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 66
nalysis of Fanconi anemia genes in colorectal cancer. 66
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 66
Current Trends in Mucosal Melanomas: An Overview 65
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 64
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 64
Mutational status of main oncogenes and microsatellite instability in Sardinian patients with advanced colorectal cancer 64
Disease progression and overall survival in Sardinian patients with colorectal cancer according to the kras mutational status 63
Molecular landscape profile of melanoma 63
Genetic Instability Markers in Cancer 61
KRAS mutations in non-small cell lung cancer: Translational aspects, current therapies and challenges for future research 60
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 59
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 57
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 56
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 54
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 53
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 53
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 52
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 52
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 52
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 50
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 49
Mutational Profiles of Cutaneous Squamous Cell Carcinomas with Different Patterns of Clinical Aggression from Head and Neck Regions 48
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 47
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 45
Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches 45
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 43
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 43
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 42
Proteomic analysis in melanoma cell lines with different genotypes 41
Heterogeneous distribution of BRAF/NRAS mutations among Italian patients with advanced melanoma 40
Prevalence of EGFR, KRAS and BRAF mutations among patients with non-small-cell lung cancer from Sardinia 39
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 39
May genetic background affect the incidence rates of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma? Clues from Sardinian population 39
Primary Melanoma of the Lung: A Systematic Review 38
Prognostic impact of KRAS, NRAS, BRAF, and PIK3CA mutations in primary colorectal carcinomas: A population-based study 37
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 37
Genetic alterations at chromosome 9p21 in primary tumors and metastases from patients with sporadic melanoma: Definition of their clinical significance 35
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 35
CDKN2A mutations could influence the dermoscopic pattern of presentation of multiple primary melanoma: A clinical dermoscopic genetic study 35
Prevalence and prognostic role of microsatellite instability in patients with rectal carcinoma 35
Molecular analysis of Fanconi anemia (FA) and mismatch repair (MMR) genes in patients with colorectal carcinoma 35
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 34
Molecular analysis of appendiceal mucinous cystadenoma and rectal adenocarcinoma in a patient with urothelial carcinoma: A case report 34
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 34
Molecular classification for the management of melanoma patients. 32
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 32
High-resolution methylation analysis of the hMLH1 promoter in sporadic endometrial and colorectal carcinomas 32
Factors predicting the occurrence of germline mutations in candidate genes among patients with cutaneous malignant melanoma from South Italy 32
A novel candidate gene in human endometrial cancer at chromosome 10q26 32
DEFINITION OF THE ROLE OF CHROMOSOME 9P21 IN SPORADIC MELANOMA THROUGH GENETIC ANALYSIS OF PRIMARY TUMORS AND THEIR METASTASES 32
Heterogeneous prevalence of somatic mutations in KRAS, BRAF, and PIK3CA genes among patients with colorectal carcinoma: clues from Sardinia 31
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 31
Genetic alterations in main candidate genes during melanoma progression 31
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 30
Prevalence of BRAF and NRAS mutations in primary tumours and different types of metastasis among melanoma patients 30
Assesment of the role of Fanconi Anemia (FA) genes in colorectal cancer: A new pathogenetic pathway? 30
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 30
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 30
Fanconi genes may contribute to melanoma pathogenesis. 29
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 29
Low levels of genetic heterogeneity in matched lymph node metastases from melanoma patients 29
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 29
Prevalence of KRAS, BRAF, and PIK3CA somatic mutations in patients with colorectal carcinoma may vary in the same population: clues from Sardinia 28
Toward the characterization of a genetic profile with prognostic value at CDKN2A locus in melanoma patients. 28
Discrepant alterations in main candidate genes among multiple primary melanomas 28
Loss of Wnt4 and Foxl2 leads to Female-To-Male Sex Reversal Extending to Germ Cells 28
A pattern of polymorphic variants at the CDKN2 locus is associated with both susceptibility and prognosis in melanoma patients. 27
Epidemiological and genetic factors underlying melanoma development in Italy 27
Microsatellite instability and mutation analysis among southern Italian patients with colorectal carcinoma: detection of different alterations accounting of MLH1 and MSH2 inactivation in familial cases 27
BRAF gene is somatically mutated but does not make a major contribution to malignant melanoma susceptibility: the Italian Melanoma Intergroup study 27
COX-2 expression positively correlates with PD-L1 expression in human melanoma cells 26
Mutational analysis of candidate genes in families with malignant melanoma (MM): assessment of the role of the CDKN2A gene in MM predisposition. 26
Mutational analysis of candidate genes among patients with malignant melanoma from south Italy. 26
Role on the BRAF gene in malignant melanoma 26
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 26
Fanconi genes are altered in subsets of patients with sporadic colorectal carcinoma. 25
Epidemiological features and prognostic parameters of multiple primary melanomas in CDKN2A-mutations patients 25
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 25
Assessment of genetic instability in melanocytic skin lesions through microsatellite analysis of benign nevi, dysplastic nevi, and primary melanomas along with their metastases. 25
Mutation analysis of HMLH1-HMSH2 genes among Sardinian patients with sporadic and familial colorectal cancer 25
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 25
Mutation prevalence for candidate genes varies in melanoma population from south Italy. 25
Heterogeneous prevalence of KRAS, BRAF, and PIK3CA mutations in patients with colorectal carcinoma from Sardinia 24
High resolution methylation analysis of HMLH1 promoter in sporadic endometrial and colorectal carcinomas. 24
Role of CASC2 a gene in human endometrial cancer. 24
Genetic instability and increased mutational load: which diagnostic tool best direct patients with cancer to immuno-therapy? 24
Role of the Fanconi gene pathway into the pathogenesis of melanoma. 24
Totale 4.343
Categoria #
all - tutte 17.215
article - articoli 13.207
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 613
Totale 31.035


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202417 0 0 0 0 0 0 0 0 2 0 8 7
2024/20251.656 16 7 104 62 290 72 36 90 61 108 419 391
2025/20263.060 124 219 261 383 457 144 440 218 218 243 147 206
2026/2027207 156 51 0 0 0 0 0 0 0 0 0 0
Totale 4.940